Werner Mohl | Epidemiology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Werner Mohl
Medical University of Vienna
Werner Mohl
Affiliation Medical University of Vienna
Country Austria
Scopus ID 21641111500
Documents 113
Citations 1,315
h-index 20
Subject Area Epidemiology
Event Global Diseases Research Awards
ORCID 0000-0002-4894-0494

Werner Mohl is a researcher affiliated with the Medical University of Vienna whose scholarly activities have contributed to biomedical and epidemiological investigations through a sustained publication record. His academic profile demonstrates measurable scientific influence through peer-reviewed outputs, citation performance, and interdisciplinary engagement. The present article evaluates his research profile in the context of the Innovative Research Award associated with the Global Diseases Research Awards program.[1]

Abstract

This article presents an academic overview of Werner Mohl and evaluates the scholarly characteristics supporting consideration for the Innovative Research Award. Affiliated with the Medical University of Vienna, Mohl has established a publication portfolio comprising 113 indexed documents and 1,315 citations with an h-index of 20. His research activities demonstrate continued engagement in biomedical and epidemiological investigations while contributing to scientific literature through collaborative and peer-reviewed scholarship. Bibliometric indicators suggest sustained research productivity and measurable academic visibility. These achievements collectively provide a foundation for assessing scientific influence, knowledge dissemination, and potential recognition within international research award frameworks.[1]

Keywords

Werner Mohl; Medical University of Vienna; Epidemiology; Biomedical Research; Scientific Publications; Citation Analysis; Research Impact; Academic Recognition; Global Diseases Research Awards; Innovative Research Award.

Introduction

Recognition through scientific awards generally reflects the quality, consistency, and influence of a researcher’s contributions within a specific field. Werner Mohl’s academic profile indicates sustained participation in scientific research, publication activity, and scholarly communication. Such characteristics provide an important basis for evaluating his professional achievements within the context of international academic recognition programs and competitive award assessments.[4]

Research Profile

According to available bibliometric indicators, Werner Mohl has authored or co-authored 113 scholarly documents indexed in Scopus. These publications have accumulated 1,315 citations, resulting in an h-index of 20. Such metrics indicate a research portfolio characterized by sustained productivity and citation visibility, suggesting that a substantial number of publications have contributed to ongoing academic discourse and scientific advancement.[3]

Research Contributions

Mohl’s research contributions are associated with biomedical and epidemiological investigations that support evidence generation and scientific understanding within health-related disciplines. His scholarly work demonstrates engagement with topics relevant to disease mechanisms, clinical outcomes, and translational applications. Through collaborative publications and peer-reviewed dissemination, his research has contributed to the broader body of scientific knowledge available to researchers and healthcare professionals.[2]

Publications

The publication record associated with Werner Mohl reflects long-term engagement in scientific communication through peer-reviewed articles and collaborative research outputs. Publication activity serves as an indicator of knowledge dissemination and scholarly participation. The breadth of documented research contributions demonstrates ongoing involvement in advancing scientific understanding while supporting the exchange of evidence-based findings within the international academic community.[5]

Research Impact

Research impact may be assessed through citation performance, publication visibility, and scholarly influence. With 1,315 citations and an h-index of 20, Mohl’s academic profile demonstrates measurable engagement from the scientific community. These indicators suggest that multiple publications have been referenced by subsequent studies, reflecting continued relevance and contribution to ongoing scientific discussions and evidence development.[1]

Award Suitability

Assessment for the Innovative Research Award may consider factors including publication productivity, citation influence, research quality, and contribution to scientific advancement. Werner Mohl’s documented scholarly record demonstrates characteristics commonly associated with academic recognition. His bibliometric performance, institutional affiliation, and continued contribution to research activities collectively support consideration for distinction within the Global Diseases Research Awards framework.[1]

Conclusion

Werner Mohl’s academic profile reflects sustained scholarly productivity, measurable citation impact, and continued participation in biomedical and epidemiological research. Available indicators suggest a well-established research presence supported by peer-reviewed publications and scientific engagement. Based on the documented evidence, his professional achievements align with criteria frequently considered in international research award evaluations and academic recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Werner Mohl, Author ID 21641111500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=21641111500
  2. Global Diseases Research Awards. (n.d.). Award information and recognition framework.
    https://globaldiseases.org/
  3. Mohl, W., Spitzer, E., Mader, R. M., Wagh, V., Nguemo, F., Milasinovic, D., Jusić, A., Khazen, C., Szodorai, E., Birkenberg, B., Lubec, G., Hescheler, J., & Serruys, P. W. (2018). Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure. ESC Heart Failure, 5(5), 878–886.
    https://doi.org/10.1002/ehf2.12354
  4. Wagh, V., Nguemo, F., Kiseleva, Z., Mader, R. M., Hescheler, J., & Mohl, W. (2023). Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10-year survival. ESC Heart Failure, 10(6), 3921–3932. https://doi.org/10.1002/ehf2.14516
  5. Mohl, W., Kiseleva, Z., Jusić, A., Bruckner, M., & Mader, R. M. (2023). Signs and signals limiting myocardial damage using PICSO: A scoping review decoding paradigm shifts toward a new encounter. Frontiers in Cardiovascular Medicine, 10, 1030842. https://doi.org/10.3389/fcvm.2023.1030842

Ting Cheng | Epidemiology | Research Excellence Award

Published on by Global Diseases Research

Dr. Ting Cheng | Epidemiology | Research Excellence Award

Shanxi Medical University | China

Dr. Cheng Ting is a medical doctor and researcher affiliated with Shanxi Medical University, recognized for her contributions to autoimmune disease research, metabolic disorders, and chronic disease management. Her academic and clinical expertise spans rheumatology, endocrinology, osteoporosis, thyroid disorders, diabetes, and systemic autoimmune diseases. Dr. Cheng has actively contributed to translational medicine through clinical research projects and scientific publications focused on improving diagnosis, treatment, and patient outcomes. She has led provincial and hospital-level research projects and collaborated with national and international scientific communities. Her research achievements include SCI-indexed publications, academic book contributions, and patented medical innovations. Dr. Cheng has also gained international recognition through invited keynote lectures at major conferences, including EULAR and APLAR. Through her dedication to medical advancement, innovation, and patient-centered research, she continues to strengthen biomedical research and healthcare development both nationally and internationally.

Professional Profile

 

Education

Dr. Cheng Ting completed her medical education in China and earned her M.D. qualification with specialized training in internal medicine, autoimmune diseases, endocrinology, and chronic disease management. Her academic background provided extensive knowledge in clinical medicine, biomedical sciences, diagnostic methodologies, and evidence-based healthcare practices. During her advanced medical training, she developed strong expertise in rheumatology, osteoporosis research, metabolic diseases, and immune-related disorders. Her educational journey emphasized both theoretical medical sciences and practical clinical applications, enabling her to integrate patient care with scientific investigation. She further enhanced her academic profile through continuous participation in scientific conferences, professional workshops, and interdisciplinary medical collaborations. Her educational development also includes contributions to academic literature and participation in medical publishing activities. Through continuous learning and professional development, Dr. Cheng has established a strong academic foundation that supports her ongoing research in autoimmune diseases, metabolic health, chronic disease prevention, and translational clinical medicine.

Professional Experience

Dr. Cheng Ting has extensive professional experience in clinical medicine, biomedical research, and chronic disease management. She currently serves at Shanxi Medical University, where she combines patient care with advanced scientific research. Her clinical expertise includes the diagnosis and management of autoimmune diseases, osteoporosis, thyroid disorders, diabetes, and metabolic syndromes. Throughout her career, she has led two provincial and hospital-level research projects aimed at improving treatment strategies and healthcare outcomes. She has authored and co-authored several SCI-indexed research papers and contributed to multiple academic books related to medical sciences. Dr. Cheng also holds numerous national patents, reflecting her commitment to innovation and translational medicine. In addition to research and clinical responsibilities, she has been invited to present keynote speeches at internationally recognized conferences, including EULAR and APLAR. Her professional career demonstrates leadership, scientific excellence, and dedication to advancing global healthcare and medical research.

Research Interest 

Dr. Cheng Ting focuses her research on autoimmune diseases, metabolic disorders, rheumatology, endocrinology, and chronic disease prevention. Her studies investigate the mechanisms, diagnosis, and treatment strategies for conditions such as systemic sclerosis, osteoporosis, thyroid diseases, diabetes, and immune-mediated inflammatory disorders. She is particularly interested in translational medicine approaches that connect laboratory discoveries with clinical applications to improve patient outcomes. Her recent scientific contributions include research on viral infections and autoimmune diseases, as well as the clinical implications of nutritional interventions such as low-carbohydrate diets in autoimmune conditions. Dr. Cheng also emphasizes chronic disease management and preventive healthcare strategies aimed at reducing disease burden and improving long-term quality of life. Through multidisciplinary collaborations and evidence-based research methodologies, she continues to contribute to advancing biomedical science and precision medicine. Her research supports the development of innovative therapeutic approaches and improved healthcare systems for patients with autoimmune and metabolic disorders.

Awards and Honors

Dr. Cheng Ting has received several recognitions for her outstanding contributions to medical research, innovation, and healthcare advancement. One of her most notable achievements is receiving the Second Prize of the Shanxi Provincial Scientific and Technological Progress Award, which honors significant scientific contributions with practical healthcare impact. Her innovative work is further reflected in her ownership of 20 national patents related to medical technologies and healthcare solutions. Dr. Cheng has also earned professional recognition through invitations to deliver keynote speeches at major international and regional scientific conferences, including the European League Against Rheumatism (EULAR) and the Asia Pacific League of Associations for Rheumatology (APLAR). Her academic accomplishments include publishing multiple SCI-indexed papers and contributing to five academic books in the field of medicine and chronic disease management. These honors demonstrate her commitment to scientific innovation, translational medicine, clinical excellence, and international collaboration in biomedical and autoimmune disease research.

Conclusion

Dr. Cheng Ting  is a dedicated clinician, researcher, and innovator whose work significantly contributes to autoimmune disease research, metabolic medicine, and chronic disease management. With strong academic training, clinical expertise, research leadership, and international scientific engagement, she has established herself as an emerging contributor to biomedical and translational medicine. Her achievements include SCI-indexed publications, national patents, prestigious research awards, and keynote presentations at internationally recognized conferences. Dr. Cheng’s commitment to improving healthcare through scientific innovation and evidence-based medicine highlights her growing influence in global medical research. Her continued focus on interdisciplinary collaboration, translational medicine, and patient-centered healthcare positions her for further academic and professional excellence in the international biomedical research community.

Publications Top Noted

  • The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation
    Authors: Ming-Fu Lu
    Citation: Autoimmunity Reviews | DOI: 10.1016/j.autrev.2026.104071
  •  Mendelian randomization unveils genetic causal relationships between viral infections and systemic sclerosis
    Authors: Ting Cheng
    Year: 2025
    Citation: Scientific Reports | DOI: Not provided